髋关节镜失败后行髋关节置换术的结局:病例对照研究
该病例对照研究将35例既往同侧髋关节镜后行髋关节置换术的患者与70例同期无关节镜史的初次置换患者按年龄、性别和假体类型匹配,比较活动度、假体生存率、并发症和功能评分。结果显示两组术后活动度改善、并发症率及功能改善均无显著差异,7年总体假体生存率为85.9%,11例翻修中10例为金属对金属髋表面置换的不良金属反应。作者结论认为髋关节镜不会对后续髋关节置换术的结局产生不良影响。
要点
- 既往髋关节镜后行髋关节置换术与无关节镜史者相比,术后活动度改善无显著差异。
- 两组并发症率、功能评分改善及假体生存率均无显著差异。
- 11例翻修中10例为金属对金属髋表面置换的不良金属反应。
核心结论
- 本研究显示髋关节镜不会对后续髋关节置换术的结局产生不良影响。
研究设计与样本
- 采用前瞻性收集的数据,识别35例既往同侧髋关节镜后行髋关节置换术的患者(22例全髋关节置换和13例髋表面置换)作为病例组。
- 病例组按年龄、性别和假体类型与70例同期无关节镜史的初次髋关节置换患者(对照组)匹配。
- 结局指标包括活动度、假体生存率、并发症和功能结局(牛津髋关节评分和哈里斯髋关节评分)。
主要发现
- 两组髋关节置换术后活动度改善在所有运动轴(屈曲、伸展、内旋/外旋、外展和内收)均无显著差异(P=0.07-0.78)。
- 两组并发症率无显著差异(P=0.72)。
- 总体7年假体生存率为85.9%(95%CI 75-95.8)。
- 病例组与对照组假体生存率无差异:病例组87.6%(95%CI 73.5-100)vs 对照组86.3%(95%CI 74.6%-98.0%),P=0.2。
- 11例翻修关节置换术中10例为金属对金属髋表面置换的不良金属反应(P=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hip arthroscopy is increasingly being used in joint preservation surgery with clear benefits in the treatment of prearthritic conditions. A number of patients, however, will still go on to require subsequent hip arthroplasty, and at present, little evidence exists determining the impact that prior hip arthroscopy may have on the outcomes of a subsequent arthroplasty. METHODS: Using prospectively collated data, we identified 35 patients who had a hip arthroplasty (22 total hip arthroplasties and 13 hip resurfacing arthroplasties) after prior ipsilateral hip arthroscopy (cases). Cases were matched for age, gender, and prosthesis type with 70 controls (patients who received a primary arthroplasty over the same period, without prior arthroscopy). Outcome measures included range of movement, implant survival, complications, and functional outcome (Oxford Hip Score and Harris Hip Score). RESULTS: There was no demonstrable difference in improved range of motion after hip arthroplasty between the 2 groups, across any axis of movement (flexion, extension, internal/external rotation, abduction, and adduction; P = .07-.78). There was no significant difference in complication rate (P = .72). Overall 7-year implant survival was 85.9% (95% confidence interval [CI], 75-95.8). There was no difference in survival between cases (87.6%; 95% CI, 73.5-100) and controls (86.3%; 95% CI, 74.6%-98.0%; P = .2). Ten of the 11 revision arthroplasties performed were due to adverse reactions to metal debris in metal-on-metal hip resurfacing arthroplasty cases (P = .01). There was no difference in improvement of functional outcome postarthroplasty between groups (P = .48-.76). CONCLUSION: This study demonstrates that hip arthroscopy does not adversely influence outcome of a subsequent hip arthroplasty.
引用
- Parker SJM, Grammatopoulos G, Davies OLI, et al. Outcomes of Hip Arthroplasty After Failed Hip Arthroscopy: A Case-Control Study. J Arthroplasty. 2017. PMID: 28602531. doi:10.1016/j.arth.2017.05.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。